Variant Bio is developing therapies that will improve global health by studying the genes of people who are outliers for medically relevant traits.
Location: United States
Employees: 11-50
Total raised: $25M
Founded date: 2018
Investors 3
| Date | Name | Website |
| 15.08.2020 | Alta Partn... | altapartne... |
| - | Lux Capita... | luxcapital... |
| - | Sahsen Ven... | sahsen.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.08.2020 | Series A | $25M | - |
Mentions in press and media 1
| Date | Title | Description |
| 06.01.2026 | Variant Bio launches AI-powered platform for drug discovery using genetic data | Jan 6 : Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human trials. Drug developers are increasing adoption of... |